Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | POLB | P06746 | 3/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9402317 | 0.98 | KMT2A (0.59) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL11538261 | 0.87 | KMT2A (0.52) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL27536602 | 0.84 | KMT2A (0.52) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL3577958 | 0.81 | ALOX5 (0.58) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL9402314 | 0.81 | ALOX5 (0.49) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL15291349 | 0.79 | KMT2A (0.62) | KMT2APOLBPTPN1L3MBTL1PKM | |
| Hydrochloric Acid SCHEMBL5352590 | 0.79 | ALOX5 (0.56) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL5511586 | 0.79 | KMT2A (0.57) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL31612145 | 0.78 | HTT (0.43) | KMT2APOLBPTPN1L3MBTL1PKM | |
| SCHEMBL5158147 | 0.78 | KMT2A (0.60) | KMT2APOLBPTPN1L3MBTL1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3509647-B1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2020-10-21 | — | — | EP | claimed |
| CN-105693772-B | A kind of compound and its application in DNA end group modifications | 中国石油大学(华东) | 2017-03-15 | — | — | CN | claimed |
| CN-105693772-A | Compound and application thereof to DNA end group modification | 中国石油大学(华东) | 2016-06-22 | — | — | CN | claimed |
| EP-1945224-B1 | REDUCTION OF SIDE EFFECTS FROM AROMATASE INHIBITORS USED FOR TREATING BREAST CANCER | CHAVAH PTY LTD (AU) | 2012-05-02 | — | — | EP | claimed |
| EP-1359920-B1 | USES OF ORAL FORMULATIONS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION | BARR LAB INC (US) | 2007-08-22 | — | — | EP | claimed |
| US-20050042268-A1 | Pharmaceutical composition and method for transdermal drug delivery | PERRIGO ISRAEL PHARMACEUTICALS LTD. (IL) | 2005-02-24 | — | — | US | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| JP-3034046-B2 | — | — | 2000-04-17 | — | — | JP | claimed |
| EP-0691953-A1 | 1-AMIDINOPHENYL-PYRROLIDONES PIPERIDINONES AZETINONES AS PLATELET AGGREGATION INHIBITORS | G.D. SEARLE & CO. (US) | 1996-01-17 | — | — | EP | claimed |
| WO-1994022820-A1 | 1-AMIDINOPHENYL-PYRROLIDONES PIPERIDINONES AZETINONES AS PLATELET AGGREGATION INHIBITORS | G.D. SEARLE & CO. (US) | 1994-10-13 | — | — | WO | claimed |
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2026-04-16 | — | — | US | disclosed |
| US-12528801-B2 | Substituted azacyles as TRPM8 modulators | GIVAUDAN SA (CH) | 2026-01-20 | — | — | US | disclosed |
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250186600-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2025-06-12 | — | — | US | disclosed |
| CN-114555594-B | Substituted azacycles as TRMP modulators | 奇华顿股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| EP-0076721-B1 | PROCESS FOR THE CARBONYLATION OF SECONDARY BENZYL HALIDES | Montedison S.p.A. (IT) | 1985-02-06 | — | — | EP | disclosed |
| EP-0076721-A1 | Process for the carbonylation of secondary benzyl halides | Montedison S.p.A. (IT) | 1983-04-13 | — | — | EP | disclosed |
| US-4107178-A | Thioprene or furan derivatives and process for preparation thereof | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4086420-A | Thioprene or furan derivatives and process for preparation thereof | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1978-04-25 | — | — | US | disclosed |
| US-4051151-A | Thiophene derivatives and process for preparation thereof | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | TRPM8, TRPM7, TRPM5 | KMT2A 2019/4885POLB 4267/4885PTPN1 2038/4885 |
| US-12528801-B2 | Substituted azacyles as TRPM8 modulators | TRPM8, TRPM7, TRPM4 | KMT2A 2021/4885POLB 4565/4885PTPN1 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.